1cP-LSD

Source: Wikipedia, the free encyclopedia.
1cP-LSD
Clinical data
Routes of
administration		By mouth, under the tongue
Legal status
Legal status
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4-cyclopropylmethanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
JSmol)
  • CCN(CC)C(=O)[C@@H]5C=C2[C@@H](Cc3cn(C(=O)C1CC1)c4cccc2c34)N(C)C5
  • InChI=1S/C24H29N3O2/c1-4-26(5-2)23(28)17-11-19-18-7-6-8-20-22(18)16(12-21(19)25(3)13-17)14-27(20)24(29)15-9-10-15/h6-8,11,14-15,17,21H,4-5,9-10,12-13H2,1-3H3/t17-,21-/m1/s1
  • Key:RAFUPYYDHPFASC-DYESRHJHSA-N

1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an

lysergic acid diethylamide (LSD), which has been sold as a designer drug
.
psychedelic with similar potency to 1P-LSD.[3]

Legal status

1cP-LSD on blotter paper

dangerous substance on 18 December 2019 and later classified it as such on 22 April 2021.[4][5]

See also

References

  1. PMID 33132277
    .
  2. PMID 34371393
    .
  3. PMID 32180350
    .
  4. ^ "Förordning (1999:58) om förbud mot vissa hälsofarliga varor".
  5. ^ "Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara" [Twenty-three substances are proposed to be classified as drugs or dangerous goods] (in Swedish). Folkhälsomyndigheten. December 18, 2019. Archived from the original on November 24, 2022. Retrieved May 28, 2020.
Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=1cP-LSD&oldid=1205629650"